Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.270
-0.020 (-1.55%)
Aug 7, 2025, 4:00 PM - Market closed
ACRV's stock price has decreased by -82.34% in the past year and price targets may not have had time to catch up.
Acrivon Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$17.60
Upside
+1,285.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 16, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +608.66% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +1,396.06% | Mar 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 26, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $17 | Buy | Reiterates | $17 | +1,238.58% | Mar 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +1,396.06% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 31, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $28 → $27 | Buy | Maintains | $28 → $27 | +2,025.98% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +1,632.28% | Nov 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +1,238.58% | Sep 16, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $16 | Hold → Strong Buy | Upgrades | $16 | +1,159.84% | Sep 16, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $25 → $28 | Buy | Reiterates | $25 → $28 | +2,104.72% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +1,632.28% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +1,632.28% | Aug 13, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $25 | Buy | Reiterates | $25 | +1,868.50% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +1,632.28% | May 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.